Polypeptide and use thereof

MYPI2025006588A0Undetermined Publication Date: 2024-10-26BIOCELLS BEIJING BIOTECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025006588
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-12-27
Filing Date
2024-04-23
Publication Date
2024-10-26

Smart Images

  • Figure PI2025006588_DRAWING_001
    Figure PI2025006588_DRAWING_001
  • Figure PI2025006588_DRAWING_002
    Figure PI2025006588_DRAWING_002
  • Figure PI2025006588_DRAWING_003
    Figure PI2025006588_DRAWING_003
Patent Text Reader

Abstract

The present invention belongs to the field of biotechnology. Provided is a polypeptide and the use thereof. The polypeptide is established on the basis of a mechanism study on an ETBR agonist, and belongs to a highly selective agonist of ETBR. The polypeptide prolongs the half-life of a drug, increases in vivo exposure, and reduces the frequency of administration by means of study on structure-activity relationship and structural modification, and has a lower side effect than that of IRL-1620 in animal experiments, and a larger safety window of a drug. The polypeptide can be used for treating diseases related to an ETBR receptor, such as rehabilitation treatment of a patient with ischemic stroke in the acute stage and the recovery stage, so as to promote better recovery of the patient with stroke. [No suitable figure]
Need to check novelty before this filing date? Find Prior Art